The formulation is a trade secret. Paul Hyslop has said that he discussed patenting the zoono molecule with patent lawyers but he was advised that if he did so, the formulation would be in public domain and all it would take is a competitor to modify it by 5% and they could legally call it 'different'. He was thus advised against registering it as a patent and keeping it a trade secret.
The formulation is a trade secret. Paul Hyslop has said that he...
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.003(11.1%) |
Mkt cap ! $6.412M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $2.297K | 76.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35640 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 2411 | 1 |
View Market Depth
| Last trade - 15.44pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
0.003 ( 3.45 %) |
||||
| Open | High | Low | Volume | ||
| 2.7¢ | 3.0¢ | 2.7¢ | 41920 | ||
| Last updated 15.39pm 07/05/2024 ? | |||||
| ZNO (ASX) Chart |